5Johnson M. Interactions between Corticosteroids and β2-Agonistsin in Asthma and Chronic Obstructive Pulmonary Disease[ J]. Proc Am Thorac Soc,2004,1:200 - 6.
6Mark L Levya, Mike Thomasb, Iain R Smallc, et al. Summary of the 2008 BTS/SIGN British Guideline on the Management of Asthma [ J ]. Primary Care Respiratory Journal,2009,18, Suppl 1 : S1-16.
7Manminder Kaur, Neit S. Holden, Sylvia M. Wilson, et al. Effect of β2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells : a role for protein kinase A [ J ]. Am J Physiol Lung Cell Mol Physiol, 2008,295 : 505 -5.
8Mark Salter, Keith Biggadike ,Joyce E. Matthews, et al. Pharmacological properties of the enhanced-affinity gtucocorticoid fluticasone furoate in vitro and in vivo model of respiratory inflammatory disease [ J]. Am J Physiol Lung Cell Mol Physiol,2007 ,293 :660 -7.
9Manminder Kaur, Joanna E. Chivers, Mark A. Giembycz,et al. Long- Acting β2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells [ J ]. Molecular Pharmacology, 2008,73 ( 1 ) :203 -14.
10Karl-Christian Bergmanna, L. Lindemannb, R. Braunc, et al. Salmet- erol/flutieasone propionate(50/250 nag) combination is superior to double dose fluticasone (500 mg) for the treatment of symptomatic moderate asthma[ J]. Swiss reed Wkly,2004,134:50-8.
